Rarebase
Michael Blanco has a range of research experience in the field of life sciences. Michael started their career as an Undergraduate Research Assistant at the University of California, Santa Cruz in 2015 and then became a Teaching Assistant and Graduate Student Researcher until 2018. Michael then worked as a Research Associate II at Genentech from 2018 to 2019. Michael then joined Stanford University as a Life Science Research Professional from 2019 to 2023. Currently, they are working at Rarebase, initially as a Research Associate 2 and currently as a Principal Research Associate.
Michael Blanco received a Bachelor of Science (B.S.) degree in Molecular, Cell, and Developmental Biology from the University of California, Santa Cruz in 2016. Michael then pursued a Master's degree in Molecular, Cellular, and Developmental Biology from the same university, completing it in 2018.
Rarebase
Rarebase is enabling a better life for the 400 million people living with rare disease. With a product engine designed to discover treatments for hundreds of monogenic diseases simultaneously, Rarebase is focused on the largest untapped drug discovery opportunity in human health: rare diseases. Rarebase has already uncovered potential treatments for hundreds of rare diseases. The company has also built a “drug-gene atlas” to enable AI-driven drug discovery.